Citations (217)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Krishnan Silja, Natarajan Selvaganabathy, Thiyagarajan Kalaiselvi & Chinnasamy Thirunavukkarasu. (2023) Inhibition of glutathione generation in hepatic steatotic rats augments oxidative stress. Toxicology Mechanisms and Methods 33:7, pages 596-606.
Read now
Read now
Panagiotis V. Katsaounis, Emilia S. Hadjiyannis, Teressa Skaltsi, Vassiliki A. Anargyrou, Alexandra A. Alexopoulou, Spyridon P. Dourakis & John S. Koskinas. (2023) Bone disease in patients with cirrhosis of different etiology and severity; are Klotho protein and osteoprotegerin potential biomarkers?. Scandinavian Journal of Gastroenterology 58:2, pages 185-192.
Read now
Read now
Abdolmomen Ghaeni Pasavei, Reza Mohebbati, Mohammad Jalili-Nik, Hamid Mollazadeh, Ahmad Ghorbani, Abolfazl Nosrati Tirkani, Shirin Taraz Jamshidi, Seyed Isaac Hashemy, Hamid Heidarian Miri & Mohammad Soukhtanloo. (2021) Effects of Rhus coriaria L. hydroalcoholic extract on the lipid and antioxidant profile in high fat diet-induced hepatic steatosis in rats. Drug and Chemical Toxicology 44:1, pages 75-83.
Read now
Read now
Man-Chen Hung, Chuen-Fei Chen, Meng-Ting Tsou, Hsin-Hui Lin, Lee-Ching Hwang & Ching-Ping Hsu. (2020) Relationship Between Gallstone Disease and Cardiometabolic Risk Factors in Elderly People with Non-Alcoholic Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity 13, pages 3579-3585.
Read now
Read now
Fatemeh Kalaki-Jouybari, Mehrnoosh Shanaki, Maryam Delfan, Sattar Gorgani-Firouzjae & Soheyla Khakdan. (2020) High-intensity interval training (HIIT) alleviated NAFLD feature via miR-122 induction in liver of high-fat high-fructose diet induced diabetic rats. Archives of Physiology and Biochemistry 126:3, pages 242-249.
Read now
Read now
Catriona MacLean, John Dillon, John A. Babraj & Niels BJ. Vollaard. (2018) The effect of low volume sprint interval training in patients with non-alcoholic fatty liver disease. The Physician and Sportsmedicine 46:1, pages 87-92.
Read now
Read now
Fereshteh Aliasghari, Azimeh Izadi, Bahram Pourghassem Gargari & Sara Ebrahimi. (2017) The Effects of Ramadan Fasting on Body Composition, Blood Pressure, Glucose Metabolism, and Markers of Inflammation in NAFLD Patients: An Observational Trial. Journal of the American College of Nutrition 36:8, pages 640-645.
Read now
Read now
Spyros Michopoulos, Vasiliki I Chouzouri, Efstathios D Manios, Eirini Grapsa, Zoi Antoniou, Christos A Papadimitriou, Nikolaos Zakopoulos & Athanasios-Meletios Dimopoulos. (2016) Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center. Clinical and Experimental Gastroenterology 9, pages 1-9.
Read now
Read now
Reham Abdel-Wahab, Samir Shehata, Manal M Hassan, Mouhammed A Habra, Ghazaleh Eskandari, Peggy T Tinkey, Jennifer Mitchell, Ju-Seog Lee, Hesham M Amin & Ahmed O Kaseb. (2015) Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma. Journal of Hepatocellular Carcinoma 2, pages 131-142.
Read now
Read now
Pei-Li Zhu, Si-Yuan Pan, Shu-Feng Zhou, Yi Zhang, Xiao-Yan Wang, Nan Sun, Zhu-Sheng Chu, Zhi-Ling Yu & Kam-Ming Ko. (2015) Effects of combined dietary supplementation with fenofibrate and Schisandrae Fructus pulp on lipid and glucose levels and liver function in normal and hypercholesterolemic mice. Drug Design, Development and Therapy 9, pages 923-935.
Read now
Read now
Umut Emre Aykut, Umit Akyuz, Atakan Yesil, Fatih Eren, Fatma Gerin, Rabia Ergelen, Cigdem Ataizi Celikel & Yusuf Yilmaz. (2014) A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 49:11, pages 1343-1348.
Read now
Read now
Yen-Chun Lee, Jin-Shang Wu, Yi-Ching Yang, Chin-Sung Chang, Feng-Hwa Lu & Chih-Jen Chang. (2014) Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease. Scandinavian Journal of Gastroenterology 49:8, pages 1001-1006.
Read now
Read now
Angela Pirillo, Giuseppe Danilo Norata & Alberico Luigi Catapano. (2014) Postprandial lipemia as a cardiometabolic risk factor. Current Medical Research and Opinion 30:8, pages 1489-1503.
Read now
Read now
P. Ye, I. K. Cheah & B. Halliwell. (2013) A high-fat and cholesterol diet causes fatty liver in guinea pigs. The role of iron and oxidative damage. Free Radical Research 47:8, pages 602-613.
Read now
Read now
Yusuf Yilmaz, Fatih Eren, Yasar Colak, Ebubekir Senates, Cigdem Ataizi Celikel & Nese Imeryuz. (2012) Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 47:12, pages 1488-1493.
Read now
Read now
Articles from other publishers (202)
Abinash Mahapatro, Fnu Bawna, Vikash Kumar, Amir Ali Daryagasht, Siddharth Gupta, Nakka Raghuma, Saman Soltani Moghdam, Akshita Kolla, Shruti Sagar Mahapatra, Nazila Sattari, Ehsan Amini-Salehi & Sandeep S. Nayak. (2023) Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses. Clinical Nutrition ESPEN 57, pages 475-486.
Crossref
Crossref
An-Hui Jin, Yi-Fan Qian, Jiong Ren, Jin-Gang Wang, Fang Qiao, Mei-Ling Zhang, Zhen-Yu Du & Yuan Luo. (2023) PDK inhibition promotes glucose utilization, reduces hepatic lipid deposition, and improves oxidative stress in largemouth bass (Micropterus salmoides) by increasing pyruvate oxidative phosphorylation. Fish & Shellfish Immunology 140, pages 108969.
Crossref
Crossref
Marina Fuertes-Agudo, María Luque-Tévar, Carme Cucarella, Paloma Martín-Sanz & Marta Casado. (2023) Advances in Understanding the Role of NRF2 in Liver Pathophysiology and Its Relationship with Hepatic-Specific Cyclooxygenase-2 Expression. Antioxidants 12:8, pages 1491.
Crossref
Crossref
Nong Li, Weiting Xang, Shengli Wu, Danting Li, Min Chang, ChengYao Xie, Mei Yu Zhang & Huiwen Tan. (2023) Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period. Frontiers in Endocrinology 14.
Crossref
Crossref
Yu Zheng, Long Xie, Dejun Yang, Kaipei Luo & Xiaofang Li. (2023) Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: An update. Phytomedicine 113, pages 154721.
Crossref
Crossref
Yannick Dauwe, Lucile Mary, Fabiana Oliviero, Marina Grimaldi, Patrick Balaguer, Véronique Gayrard & Laïla Mselli-Lakhal. (2023) Steatosis and Metabolic Disorders Associated with Synergistic Activation of the CAR/RXR Heterodimer by Pesticides. Cells 12:8, pages 1201.
Crossref
Crossref
Keyvan Hejazi & Daniel Hackett. (2023) Effect of Exercise on Liver Function and Insulin Resistance Markers in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Medicine 12:8, pages 3011.
Crossref
Crossref
Hisanori Muto, Takashi Honda, Taku Tanaka, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Norihiro Imai, Yoji Ishizu, Keiko Maeda, Tetsuya Ishikawa, Shungo Adachi, Chikara Sato, Noriko M. Tsuji, Masatoshi Ishigami, Mitsuhiro Fujishiro & Hiroki Kawashima. (2023) Proteomic Analysis Reveals Changes in Tight Junctions in the Small Intestinal Epithelium of Mice Fed a High-Fat Diet. Nutrients 15:6, pages 1473.
Crossref
Crossref
Maria Papanastasatou & Mihalis Verykokakis. (2023) Innate-like T lymphocytes in chronic liver disease. Frontiers in Immunology 14.
Crossref
Crossref
Samira Khademzadeh, Marjan Ghazisaeidi, Mohsen Nassiri Toosi, Arash Roshanpoor & Esmaeil Mehraeen. (2023) An intelligent recommender system for people who are prone to fatty liver disease. Informatics in Medicine Unlocked 41, pages 101315.
Crossref
Crossref
Laura Huiban, Anca Trifan & Carol Stanciu. 2023. Essentials of Non-Alcoholic Fatty Liver Disease. Essentials of Non-Alcoholic Fatty Liver Disease
229
241
.
Joanne Watt, Mary Jo Kurth, Cherith N. Reid, John V. Lamont, Peter Fitzgerald & Mark W. Ruddock. (2022) Non-alcoholic fatty liver disease—A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease. Frontiers in Physiology 13.
Crossref
Crossref
Jasmine Nour, Annalisa Moregola, Monika Svecla, Lorenzo Da Dalt, Rossella Bellini, Olivier Neyrolles, Gian Paolo Fadini, Yoann Rombouts, Mattia Albiero, Fabrizia Bonacina & Giuseppe Danilo Norata. (2022) Mannose Receptor Deficiency Impacts Bone Marrow and Circulating Immune Cells during High Fat Diet Induced Obesity. Metabolites 12:12, pages 1205.
Crossref
Crossref
Aman Sharma. (2022) Lipid droplets associated perilipins protein insights into finding a therapeutic target approach to cure non-alcoholic fatty liver disease (NAFLD). Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Crossref
Lindsey Garnick, Christopher Bates, Andrey Massarsky, Pamela Spencer, Priyanka Sura, Andrew D. Monnot & Andrew Maier. (2022) Dose and exposure route analyses inform relationships between liver steatosis and 2‐amino‐2‐methyl‐1‐propanol: Implications for hazard characterization. Journal of Applied Toxicology 42:12, pages 1873-1889.
Crossref
Crossref
Stefano Fiorucci & Ginevra Urbani. (2022) GDF15 in Vascular and Liver Metabolic Disorders: A Novel Therapeutic
Target. Recent Advances in Inflammation & Allergy Drug Discovery 16:2, pages 55-59.
Crossref
Crossref
M.H. Ngu, M.N. Norhayati, Z. Rosnani & M.M. Zulkifli. (2022) Curcumin as adjuvant treatment in patients with non-alcoholic fatty liver (NAFLD) disease: A systematic review and meta-analysis. Complementary Therapies in Medicine 68, pages 102843.
Crossref
Crossref
Yuyang Ma, Xue Liu, Defu Liu, Zihao Yin, Xinyi Yang & Mingyong Zeng. (2022)
Oyster (
Crassostrea gigas
) Polysaccharide Ameliorates High-Fat-Diet-Induced Oxidative Stress and Inflammation in the Liver via the Bile Acid-FXR-AMPKα Pathway
. Journal of Agricultural and Food Chemistry 70:28, pages 8662-8671.
Crossref
Crossref
Zahra Moayedfard, Farnaz Sani, Aliakbar Alizadeh, Kamran Bagheri Lankarani, Mohammad Zarei & Negar Azarpira. (2022) The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Research & Therapy 13:1.
Crossref
Crossref
Omar Abunofal & Chandra Mohan. (2022) Salubrious Effects of Green Tea Catechins on Fatty Liver Disease: A Systematic Review. Medicines 9:3, pages 20.
Crossref
Crossref
Yong-Chen Ke, Tzu-Chien Chen, Rui-Chian Tang, Jhih-Ni Lin & Feng-Huei Lin. (2022) Development of resveratrol with thiolated alginate as a supplement to prevent nonalcoholic fatty liver disease (NAFLD). APL Bioengineering 6:1.
Crossref
Crossref
Ewa Garbiec, Judyta Cielecka-Piontek, Magdalena Kowalówka, Magdalena Hołubiec & Przemysław Zalewski. (2022) Genistein—Opportunities Related to an Interesting Molecule of Natural Origin. Molecules 27:3, pages 815.
Crossref
Crossref
Mikayla A. Schmidt & Lewis R. Roberts. 2022. Hepatobiliary Cancers: Translational Advances and Molecular Medicine. Hepatobiliary Cancers: Translational Advances and Molecular Medicine
137
165
.
Chengyuan Liang, Juan Li, Bin Tian, Lei Tian, Yuzhi Liu, Jingyi Li, Liang Xin, Jun Wang, Chao Fu, Zhenfeng Shi, Juan Xia, Yiting Liang & Kun Wang. (2021) Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment. Biomedicine & Pharmacotherapy 144, pages 112298.
Crossref
Crossref
Vishal Dhruva, Christy Lawson, Caitlin Green & Carolyn Newberry. (2021) “The Gluten-Free Diet and Its Relationship with Metabolic Syndrome: Dietary Friend or Foe?”. Current Nutrition Reports 10:4, pages 282-287.
Crossref
Crossref
Sheida Zeraattalab-Motlagh, Ahmad Jayedi & Sakineh Shab-Bidar. (2021) The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials. The American Journal of Clinical Nutrition 114:5, pages 1675-1685.
Crossref
Crossref
Husam M. Salah, Ambarish Pandey, Anzhela Soloveva, Manal F. Abdelmalek, Anna Mae Diehl, Cynthia A. Moylan, Kara Wegermann, Vishal N. Rao, Adrian F. Hernandez, Ryan J. Tedford, Kishan S. Parikh, Robert J. Mentz, Robert W. McGarrah & Marat Fudim. (2021) Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction. JACC: Basic to Translational Science 6:11, pages 918-932.
Crossref
Crossref
MC Üstüner, C Tanrikut, D Üstüner, UK Kolaç, Z Özdemir Köroğlu, D Burukoğlu & E Entok. (2021) The effect of baicalein on endoplasmic reticulum stress and autophagy on liver damage. Human & Experimental Toxicology 40:10, pages 1624-1633.
Crossref
Crossref
Jaskamal Padda, Khizer Khalid, Anwar Khedr, Fahriba Tasnim, Ola A Al-Ewaidat, Ayden Charlene Cooper & Gutteridge Jean-Charles. (2021) Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus. Cureus.
Crossref
Crossref
Judith Estrada-Meza, Jasmine Videlo, Clara Bron, Cécile Saint-Béat, Marine Silva, François Duboeuf, Olivier Peyruchaud, Fabienne Rajas, Gilles Mithieux & Amandine Gautier-Stein. (2021) Tamoxifen Treatment in the Neonatal Period Affects Glucose Homeostasis in Adult Mice in a Sex-Dependent Manner. Endocrinology 162:7.
Crossref
Crossref
Yao Wang, Jiabin Hong, Ming Shi, Lianxian Guo, Linhua Liu, Huanwen Tang & Xiaoshan Liu. (2021) Triphenyl phosphate disturbs the lipidome and induces endoplasmic reticulum stress and apoptosis in JEG-3 cells. Chemosphere 275, pages 129978.
Crossref
Crossref
Komal Thapa, Ajmer Singh Grewal, Neha Kanojia, Lata Rani, Neelam Sharma & Sukhbir Singh. (2021) Alcoholic and Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development. Current Drug Discovery Technologies 18:3, pages 333-353.
Crossref
Crossref
Yi Chia Wu, Philip M. Chuang, Rachel Pinotti, Ankita Nagirimadugu, Nelson Valentin & Amreen Dinani. (2020) The association of impaired lung function and nonalcoholic fatty liver disease: a systematic review. European Journal of Gastroenterology & Hepatology 33:5, pages 745-751.
Crossref
Crossref
Dalia El Khoury, Rosemary J. Pauley & Carol Lynn Berseth. (2021) Dietary approaches to managing nonalcoholic fatty liver disease. The Nurse Practitioner 46:2, pages 19-26.
Crossref
Crossref
Breann E Abernathy, Tonya C Schoenfuss, Allison S Bailey & Daniel D Gallaher. (2021) Polylactose Exhibits Prebiotic Activity and Reduces Adiposity and Nonalcoholic Fatty Liver Disease in Rats Fed a High-Fat Diet. The Journal of Nutrition 151:2, pages 352-360.
Crossref
Crossref
Ankita Sharma, Sumit Kr AnandNeha SinghAkshay Dwarkanath, Upendra Nath Dwivedi & Poonam Kakkar. (2021) Berbamine induced activation of the SIRT1/LKB1/AMPK signaling axis attenuates the development of hepatic steatosis in high-fat diet-induced NAFLD rats. Food & Function 12:2, pages 892-909.
Crossref
Crossref
YUE WANG, YINPING DUAN, KUNLIN CHEN, HUIXIA LI & YAN QUAN. (2021) Protective effects of docosahexaenoic acid against non-alcoholic hepatic steatosis through activating of JAK2/STAT3 signaling pathway. BIOCELL 45:2, pages 307-316.
Crossref
Crossref
Xue Chen, George K. Acquaah-Mensah, Krista L. Denning, Jonathan M. Peterson, Kesheng Wang, James Denvir, Feng Hong, Arthur I. Cederbaum & Yongke Lu. (2020) High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology 319:5, pages G626-G635.
Crossref
Crossref
Siân P Cartland, Nicole Tamer, Manisha S Patil, Belinda A Di Bartolo & Mary M Kavurma. (2020) A “Western Diet” promotes symptoms of hepatic steatosis in spontaneously hypertensive rats. International Journal of Experimental Pathology 101:5, pages 152-161.
Crossref
Crossref
A. V. Anisonyan, Yu. G. Sandler, T. Yu. Khaimenova, V. A. Keyan, K. G. Saliev, E. S. Sbikina & E. V. Vinnitskaya. (2020) Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics. Terapevticheskii arkhiv 92:8, pages 73-78.
Crossref
Crossref
Arturo Solano-Urrusquieta, José A. Morales-González, Graciela E. Castro-Narro, Eira Cerda-Reyes, Perla D. Flores-Rangel & Raul Fierros-Oceguera. (2020) NRF-2 and nonalcoholic fatty liver disease. Annals of Hepatology 19:5, pages 458-465.
Crossref
Crossref
Samaneh Hosseinabadi, Maryam Rafraf, Abolfazl Mahmoodzadeh, Mohammad Asghari-Jafarabadi & Somayyeh Asghari. (2020) Effects of green coffee extract supplementation on glycemic indexes, leptin, and obesity values in patients with non-alcoholic fatty liver disease. Journal of Herbal Medicine 22, pages 100340.
Crossref
Crossref
Karan Devasani, Rachna Kaul & Anuradha Majumdar. (2020) Supplementation of pyrroloquinoline quinone with atorvastatin augments mitochondrial biogenesis and attenuates low grade inflammation in obese rats. European Journal of Pharmacology 881, pages 173273.
Crossref
Crossref
Claire M. Doskey, Kelly A. Fader, Rance Nault, Todd Lydic, Jason Matthews, Dave Potter, Bonnie Sharratt, Kurt Williams & Tim Zacharewski. (2020) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters hepatic polyunsaturated fatty acid metabolism and eicosanoid biosynthesis in female Sprague-Dawley rats. Toxicology and Applied Pharmacology 398, pages 115034.
Crossref
Crossref
Yu Song, Wangfei Wu, Liang Sheng, Bijie Jiang, Xiao Li & Keshu Cai. (2020) Chrysin ameliorates hepatic steatosis induced by a diet deficient in methionine and choline by inducing the secretion of hepatocyte nuclear factor 4α‐dependent very low‐density lipoprotein. Journal of Biochemical and Molecular Toxicology 34:7.
Crossref
Crossref
Natalie Chaves Cayuela, Marcia Kiyomi Koike, Jacqueline Jacysyn, Roberto Rasslan, Anderson Azevedo Cerqueira, Soraia Pereira Costa, José Picanço Diniz-Júnior, Edivaldo Massazo Utiyama & Edna Frasson de Souza Montero. (2020) N-Acetylcysteine Reduced Ischemia and Reperfusion Damage Associated with Steatohepatitis in Mice. International Journal of Molecular Sciences 21:11, pages 4106.
Crossref
Crossref
Cesar Agostinis-Sobrinho, Sofia Emanuelle de Castro Ferreira Vicente, Justina Kievišienė, Luís Lopes, Ana Raimunda Dâmaso, Sigute Norkiene, Rafaela Rosário, Raquel Munhoz da Silveira Campos, Robinson Ramirez-Velez, Jorge Mota & Rute Santos. (2020) High levels of adiponectin attenuate the detrimental association of adiposity with insulin resistance in adolescents. Nutrition, Metabolism and Cardiovascular Diseases 30:5, pages 822-828.
Crossref
Crossref
ChangHyuk Kwon, Jaw Long Sun, Ji Hoon Jeong & Tae Woo Jung. (2020) Humanin attenuates palmitate-induced hepatic lipid accumulation and insulin resistance via AMPK-mediated suppression of the mTOR pathway. Biochemical and Biophysical Research Communications 526:2, pages 539-545.
Crossref
Crossref
Qinyu Wang, Yangjie Ou, Guomin Hu, Cong Wen, Shanshan Yue, Cong Chen, Lu Xu, Jiawei Xie, Hui Dai, Han Xiao, Youyi Zhang & Rong Qi. (2020) Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice. British Journal of Pharmacology 177:8, pages 1806-1821.
Crossref
Crossref
Eui-Seong Park, Ting Yu, Kiho Yang, Shinil Choi, Seung-Min Lee & Kun-Young Park. (2020) Cube natural sea salt ameliorates obesity in high fat diet-induced obese mice and 3T3-L1 adipocytes. Scientific Reports 10:1.
Crossref
Crossref
Yuanyuan Hu, Fawen Yin, Zhongyuan Liu, Hongkai Xie, Yunsheng Xu, Dayong Zhou & Beiwei Zhu. (2020) Acerola polysaccharides ameliorate high-fat diet-induced non-alcoholic fatty liver disease through reduction of lipogenesis and improvement of mitochondrial functions in mice. Food & Function 11:1, pages 1037-1048.
Crossref
Crossref
Chantal Bémeur & Christopher F. Rose. 2020. Frailty and Sarcopenia in Cirrhosis. Frailty and Sarcopenia in Cirrhosis
247
263
.
Qing Xiong, Yuwen Wu, Miao Yang, Guijun Wu, Ye Wang, Huawei Wang, Jieyuan Feng, Linyang Song, Beier Tong, Guangzhen He & Yancheng Xu. (2019) Nr2e1 ablation impairs liver glucolipid metabolism and induces inflammation, high-fat diets amplify the damage. Biomedicine & Pharmacotherapy 120, pages 109503.
Crossref
Crossref
Fabienne Rajas, Amandine Gautier-Stein & Gilles Mithieux. (2019) Glucose-6 Phosphate, a Central Hub for Liver Carbohydrate Metabolism. Metabolites 9:12, pages 282.
Crossref
Crossref
Caroline D. Veloso, Getachew D. Belew, Luciana L. Ferreira, Luís F. Grilo, John G. Jones, Piero Portincasa, Vilma A. Sardão & Paulo J. Oliveira. (2019) A Mitochondrial Approach to Cardiovascular Risk and Disease. Current Pharmaceutical Design 25:29, pages 3175-3194.
Crossref
Crossref
Ameneh Khodarahmi, Azam Eshaghian, Fatemeh Safari & Ali Moradi. (2019) Quercetin Mitigates Hepatic Insulin Resistance in Rats with Bile Duct Ligation Through Modulation of the STAT3/SOCS3/IRS1 Signaling Pathway. Journal of Food Science 84:10, pages 3045-3053.
Crossref
Crossref
Ying Wang, Jiayi Song, Hongyan Bian, Jiaqi Bo, Shuangyu Lv, Weitong Pan & Xinrui Lv. (2019) Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells. Molecular and Cellular Biochemistry 460:1-2, pages 205-215.
Crossref
Crossref
Darren M. Gordon, Samuel O. Adeosun, Somtochukwu I. Ngwudike, Christopher D. Anderson, John E. Hall, Terry D. HindsJr.Jr. & David E. Stec. (2019) CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation. Archives of Biochemistry and Biophysics 672, pages 108072.
Crossref
Crossref
Anastasia Kontana & Konstantinos Tziomalos. (2019) Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease. World Journal of Gastroenterology 25:28, pages 3664-3668.
Crossref
Crossref
Jianying Bai, Zhen He, Yaofu Li, Xuexia Jiang, Hongmei Yu & Qing Tan. (2019) Mono-2-ethylhexyl phthalate induces the expression of genes involved in fatty acid synthesis in HepG2 cells. Environmental Toxicology and Pharmacology 69, pages 104-111.
Crossref
Crossref
Hongwei Chen, Jue Wang, Zheng Li, Christopher Wai Kei Lam, Ying Xiao, Qibiao Wu & Wei Zhang. (2019) Consumption of Sugar-Sweetened Beverages Has a Dose-Dependent Effect on the Risk of Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Dose-Response Meta-Analysis. International Journal of Environmental Research and Public Health 16:12, pages 2192.
Crossref
Crossref
Youngjae Ryu, Sung Woo Kim, Yoon Young Kim & Seung-Yup Ku. (2019) Animal Models for Human Polycystic Ovary Syndrome (PCOS) Focused on the Use of Indirect Hormonal Perturbations: A Review of the Literature. International Journal of Molecular Sciences 20:11, pages 2720.
Crossref
Crossref
Ouahiba Sihali-Beloui, Djamila Aroune, Fella Benazouz, Adile Hadji, Salima El-Aoufi & Sergio Marco. (2019) A hypercaloric diet induces hepatic oxidative stress, infiltration of lymphocytes, and mitochondrial reshuffle in Psammomys obesus, a murine model of insulin resistance. Comptes Rendus Biologies 342:5-6, pages 209-219.
Crossref
Crossref
Xu Li & Pujun Gao. (2019) Fatty liver increases gallstone disease risk in younger Chinese patients. Medicine 98:22, pages e15940.
Crossref
Crossref
Akinobu Takaki, Seiji Kawano, Daisuke Uchida, Masahiro Takahara, Sakiko Hiraoka & Hiroyuki Okada. (2019) Paradoxical Roles of Oxidative Stress Response in the Digestive System before and after Carcinogenesis. Cancers 11:2, pages 213.
Crossref
Crossref
Haneesha Mohan, Sydney L. Brandt, Ja Hyun Kim, Frances Wong, Mi Lai, Kacey J. Prentice, Dana Al Rijjal, Lilia Magomedova, Battsetseg Batchuluun, Elena Burdett, Alpana Bhattacharjee, Carolyn L. Cummins, Denise D. Belsham, Brian Cox, Ying Liu & Michael B. Wheeler. (2019) 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) prevents high fat diet-induced insulin resistance via maintenance of hepatic lipid homeostasis. Diabetes, Obesity and Metabolism 21:1, pages 61-72.
Crossref
Crossref
Wenting Shang, Haoxia Li, Padraig Strappe, Zhongkai Zhou & Chris Blanchard. (2019) Konjac glucomannans attenuate diet-induced fat accumulation on livers and its regulation pathway. Journal of Functional Foods 52, pages 258-265.
Crossref
Crossref
María del Carmen Baez, Mariana Tarán, Mónica Moya & María de la Paz Scribano Parada. 2019. Modulation of Oxidative Stress in Heart Disease. Modulation of Oxidative Stress in Heart Disease
313
338
.
Kensaku Fukunaga, Hitomi Imachi, Jingya Lyu, Tao Dong, Seisuke Sato, Tomohiro Ibata, Toshihiro Kobayashi, Takuo Yoshimoto, Kazuko Yonezaki, Toru Matsunaga & Koji Murao. (2018) IGF1 suppresses cholesterol accumulation in the liver of growth hormone-deficient mice via the activation of ABCA1. American Journal of Physiology-Endocrinology and Metabolism 315:6, pages E1232-E1241.
Crossref
Crossref
Yanchun Li, Zhongyang Lu, Ji Hyun Ru, Maria F. Lopes-Virella, Timothy J. Lyons & Yan Huang. (2018) Saturated fatty acid combined with lipopolysaccharide stimulates a strong inflammatory response in hepatocytes in vivo and in vitro. American Journal of Physiology-Endocrinology and Metabolism 315:5, pages E745-E757.
Crossref
Crossref
Hong Min Kim, Yuna Kim, Eun Soo Lee, Ji Hye Huh & Choon Hee Chung. (2018) Caffeic acid ameliorates hepatic steatosis and reduces ER stress in high fat diet–induced obese mice by regulating autophagy. Nutrition 55-56, pages 63-70.
Crossref
Crossref
Janan Ghapanchi, Maryam Zahed, Abdolaziz Haghnegahdar, Niloofar Niakan & Azita Sadeghzadeh. (2018) Osteoporosis and Jaw Abnormalities in Panoramic Radiography of Chronic Liver Failure Patients. BioMed Research International 2018, pages 1-6.
Crossref
Crossref
Zunli Ke, Ziyan Zhao, Yuanyuan Zhao, Xiaodan Xu, Yin Li, Si Tan, Cheng Huang & Zhiqin Zhou. (2018) PMFs-rich Citrus extract prevents the development of non-alcoholic fatty liver disease in C57BL/6J mice induced by a high-fat diet. Journal of Functional Foods 47, pages 28-39.
Crossref
Crossref
Nathan T. Roberts, Diego Hernando, James H. Holmes, Curtis N. Wiens & Scott B. Reeder. (2018) Noise properties of proton density fat fraction estimated using chemical shift-encoded MRI. Magnetic Resonance in Medicine 80:2, pages 685-695.
Crossref
Crossref
Daisuke Uchida, Akinobu Takaki, Takuya Adachi & Hiroyuki Okada. (2018) Beneficial and Paradoxical Roles of Anti-Oxidative Nutritional Support for Non-Alcoholic Fatty Liver Disease. Nutrients 10:8, pages 977.
Crossref
Crossref
Ying Guo, Xiuqing Han, Hongxia Che, Zhaojie Li, Ping Dong, Changhu Xue, Tiantian Zhang & Yuming Wang. (2018) Synergistic effect of eicosapentaenoic acid-enriched phospholipids and sea cucumber saponin on orotic acid-induced non-alcoholic fatty liver disease in rats. Royal Society Open Science 5:7, pages 172182.
Crossref
Crossref
Lays Lopes, Maria Martins, Luciana Farias, Ana Brito, Geovanni Lima, Vanessa Carvalho, Cristian Pereira, Aírton Conde Júnior, Tatiana Saldanha, José Arêas, Kaesel Silva & Karoline Frota. (2018) Cholesterol-Lowering and Liver-Protective Effects of Cooked and Germinated Mung Beans (Vigna radiata L.). Nutrients 10:7, pages 821.
Crossref
Crossref
Kyu-Ho Song, Min-Young Lee, Chi-Hyeon Yoo, Song-I Lim & Bo-Young Choe. (2018) Improved quantitative fatty acid values with correction of T2 relaxation time in terminal methyl group: In vivo proton magnetic resonance spectroscopy at ultra high field in hepatic steatosis. Chemistry and Physics of Lipids 212, pages 35-43.
Crossref
Crossref
Xiaonan Liu, Yan Peng, Shuhong Chen & Qingyun Sun. (2018) An observational study on the association between major dietary patterns and non-alcoholic fatty liver disease in Chinese adolescents. Medicine 97:17, pages e0576.
Crossref
Crossref
Li-li Gong, Song Yang, Wen Zhang, Fei-fei Han, Ya-li Lv, Zi-Rui Wan, He Liu, Yang-jie Jia, Ling-ling Xuan & Li-hong Liu. (2018) Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy. Journal of Pharmacological Sciences 136:4, pages 189-195.
Crossref
Crossref
Yao Lu, Zhou Jiang, Haijiang Dai, Rujia Miao, Jingxian Shu, Haotian Gu, Xing Liu, Zhijun Huang, Guoping Yang, Alex F. Chen, Hong Yuan, Ying Li & Jingjing Cai. (2018) Hepatic leukocyte immunoglobulin‐like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1‐TRAF6 pathway. Hepatology 67:4, pages 1303-1319.
Crossref
Crossref
Sara Shojaei Zarghani, Samin Abbaszadeh, Mohammad Alizadeh, Maryam Rameshrad, Alireza Garjani & Hamid Soraya. (2018) The Eeffect of Metformin Combined with Calcium-Vitamin D3 Against Diet-Induced Nonalcoholic Fatty Liver Disease. Advanced Pharmaceutical Bulletin 8:1, pages 97-105.
Crossref
Crossref
H M Kim, B R Lee, E S Lee, M H Kwon, J H Huh, B-E Kwon, E-K Park, S-Y Chang, M-N Kweon, P-H Kim, H-J Ko & C H Chung. (2017) iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner. International Journal of Obesity 42:2, pages 270-279.
Crossref
Crossref
Ivan M. Petyaev, Pavel Y. Dovgalevsky, Natalia E. Chalyk, Victor A. Klochkov, Nigel H. Kyle & Yuriy K. Bashmakov. (2018) Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary Report. International Journal of Chronic Diseases 2018, pages 1-7.
Crossref
Crossref
Li Zhao, Zhen Cang, Honglin Sun, Xiaomin Nie, Ningjian Wang & Yingli Lu. (2017) Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease. BMC Endocrine Disorders 17:1.
Crossref
Crossref
Sikarin Upala, Veeravich Jaruvongvanich, Karn Wijarnpreecha & Anawin Sanguankeo. (2016) Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis. Journal of Bone and Mineral Metabolism 35:6, pages 685-693.
Crossref
Crossref
Yutaka Takahashi. (2017) Growth Hormone and Nonalcoholic Fatty Liver Disease: Pathophysiology and Therapeutic Application成長ホルモンから見た脂肪肝/NASHの病態と治療応用. Nihon Naika Gakkai Zasshi 106:10, pages 2254-2258.
Crossref
Crossref
Guan‑Lin Yang, Lian‑Qun Jia, Jin Wu, Yi‑Xin Ma, Hui‑Min Cao, Nan Song & Ni Zhang. (2017) Effect of tanshinone IIA on oxidative stress and apoptosis in a rat model of fatty liver. Experimental and Therapeutic Medicine.
Crossref
Crossref
Qiao-Hua Qiao, Wen-Hua Zhu, Yun-Xian Yu, Fei-Fei Huang & Li-Ying Chen. (2017) Nonalcoholic fatty liver was associated with asymptomatic gallstones in a Chinese population. Medicine 96:38, pages e7853.
Crossref
Crossref
Shan Qi, Changhong Wang, Chunfu Li, Pu Wang & Minghui Liu. (2017) Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysis. Medicine 96:32, pages e7743.
Crossref
Crossref
Yutaka Takahashi. (2017) The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver. International Journal of Molecular Sciences 18:7, pages 1447.
Crossref
Crossref
Xue Sun, Xingping Duan, Changyuan Wang, Zhihao Liu, Pengyuan Sun, Xiaokui Huo, Xiaodong Ma, Huijun Sun, Kexin Liu & Qiang Meng. (2017) Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice. European Journal of Pharmacology 806, pages 75-82.
Crossref
Crossref
Siân P. Cartland, Hanis H. Harith, Scott W. Genner, Lei Dang, Victoria C. Cogger, Melissa Vellozzi, Belinda A. Di Bartolo, Shane R. Thomas, Leon A. Adams & Mary M. Kavurma. (2017) Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice. Scientific Reports 7:1.
Crossref
Crossref
Guangyun Li, Fang Zhou, Ying Chen, Weiguo Zhang & Ning Wang. (2017) Kukoamine A attenuates insulin resistance and fatty liver through downregulation of Srebp-1c. Biomedicine & Pharmacotherapy 89, pages 536-543.
Crossref
Crossref
Feng‐Juan Yan, Xiao‐Jing Zhang, Wen‐Xin Wang, Yan‐Xiao Ji, Pi‐Xiao Wang, Yang Yang, Jun Gong, Li‐Jun Shen, Xue‐Yong Zhu, Zan Huang & Hongliang Li. (2017) The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. Hepatology 65:5, pages 1492-1511.
Crossref
Crossref
Hyeon-Soo Jeong, Kang-Hoon Kim, In-Seung Lee, Ji Young Park, Yumi Kim, Ki-Suk Kim & Hyeung-Jin Jang. (2017) Ginkgolide A ameliorates non-alcoholic fatty liver diseases on high fat diet mice. Biomedicine & Pharmacotherapy 88, pages 625-634.
Crossref
Crossref
Poyoung Shim, Dongho Choi & Yongsoon Park. (2017) Association of Blood Fatty Acid Composition and Dietary Pattern with the Risk of Non-Alcoholic Fatty Liver Disease in Patients Who Underwent Cholecystectomy. Annals of Nutrition and Metabolism 70:4, pages 303-311.
Crossref
Crossref
Kamila Kochan, Edyta Kus, Ewelina Szafraniec, Adrianna Wislocka, Stefan Chlopicki & Malgorzata Baranska. (2017) Changes induced by non-alcoholic fatty liver disease in liver sinusoidal endothelial cells and hepatocytes: spectroscopic imaging of single live cells at the subcellular level. The Analyst 142:20, pages 3948-3958.
Crossref
Crossref
Xuelin Zhang, Yang Wang & Pingsheng Liu. (2016) Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease. Protein & Cell 8:1, pages 4-13.
Crossref
Crossref
Xin Zhou, Dewu Han, Ruiling Xu, Huiwen Wu, Chongxiao Qu, Feng Wang, Xiangyu Wang & Yuanchang Zhao. (2016) Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats. Oncotarget 7:49, pages 80223-80237.
Crossref
Crossref
S. Carrión, L. Torres & O. Castañer. (2016) Cardiovascular risk protection from the Mediterranean diet and olive oil. A transcriptomic update in humans. Grasas y Aceites 67:4, pages 161.
Crossref
Crossref
Kelsey E. Seitz, Cynthia R. Smith, Stanley L. Marks, Stephanie K. Venn-Watson & Marina Ivančić. (2016)
LIVER ULTRASONOGRAPHY IN DOLPHINS: USE OF ULTRASONOGRAPHY TO ESTABLISH A TECHNIQUE FOR HEPATOBILIARY IMAGING AND TO EVALUATE METABOLIC DISEASE-ASSOCIATED LIVER CHANGES IN BOTTLENOSE DOLPHINS (
TURSIOPS TRUNCATUS
)
. Journal of Zoo and Wildlife Medicine 47:4, pages 1034-1043.
Crossref
Crossref
Haiyan Zhang, Wen-Jun Shen, Yihang Li, Alex Bittner, Stefanie Bittner, Juveria Tabassum, Yuan F. Cortez, Fredric B. Kraemer & Salman Azhar. (2016) Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats. Nutrition & Metabolism 13:1.
Crossref
Crossref
Yang Cheng, Tianlu Hou, Jian Ping, Gaofeng Chen & Jianjie Chen. (2016) Quantitative succinylome analysis in the liver of non-alcoholic fatty liver disease rat model. Proteome Science 14:1.
Crossref
Crossref
Li-li Gong, Guang-run Li, Wen Zhang, He Liu, Ya-li Lv, Fei-fei Han, Zi-rui Wan, Ming-biao Shi & Li-hong Liu. (2016) Akebia Saponin D Decreases Hepatic Steatosis through Autophagy Modulation. Journal of Pharmacology and Experimental Therapeutics 359:3, pages 392-400.
Crossref
Crossref
Joseph S. Marino, Lance A. Stechschulte, David E. Stec, Andrea Nestor-Kalinoski, Sydni Coleman & Terry D. HindsJr.Jr.. (2016) Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α. Journal of Biological Chemistry 291:50, pages 25776-25788.
Crossref
Crossref
Pushpjeet Kanwar, James E Nelson, Katherine Yates, David E Kleiner, Aynur Unalp-Arida & Kris V Kowdley. (2016) Association between metabolic syndrome and liver histology among NAFLD patients without diabetes. BMJ Open Gastroenterology 3:1, pages e000114.
Crossref
Crossref
Nirvair S. Kelley. (2016) Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans. Metabolic Syndrome and Related Disorders 14:9, pages 417-430.
Crossref
Crossref
Naomi Fleury, Sian Geldenhuys & Shelley Gorman. (2016) Sun Exposure and Its Effects on Human Health: Mechanisms through Which Sun Exposure Could Reduce the Risk of Developing Obesity and Cardiometabolic Dysfunction. International Journal of Environmental Research and Public Health 13:10, pages 999.
Crossref
Crossref
Hitoshi Nishizawa, Genzo Iguchi, Hidenori Fukuoka, Michiko Takahashi, Kentaro Suda, Hironori Bando, Ryusaku Matsumoto, Kenichi Yoshida, Yukiko Odake, Wataru Ogawa & Yutaka Takahashi. (2016) IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner. Scientific Reports 6:1.
Crossref
Crossref
Terry D. HindsJr.Jr., Samuel O. Adeosun, Abdulhadi A. Alamodi & David E. Stec. (2016) Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?. Medical Hypotheses 95, pages 54-57.
Crossref
Crossref
Liang Huiqing, Yang Jiaen, Tang Jinmo, Wu Chuncheng, Li Hongshan & Chen Shaodong. (2016) Optimization of dosage ratio of chlorogenic acid and gardenia glycosides in the treatment of rats with fatty liver disease induced by high-fat feed. Journal of Traditional Chinese Medicine 36:5, pages 683-688.
Crossref
Crossref
Yipeng Cheng, Kewei Zhang, Yang Chen, Yanchuan Li, Yuzheng Li, Kuang Fu & Rennan Feng. (2016) Associations between Dietary Nutrient Intakes and Hepatic Lipid Contents in NAFLD Patients Quantified by 1H-MRS and Dual-Echo MRI. Nutrients 8:9, pages 527.
Crossref
Crossref
Han Xue, Di Chen, Yan‐Ke Zhong, Zhen‐Diao Zhou, Shi‐Xin Fang, Ming‐Yao Li & Chuang Guo. (2016)
Deferoxamine ameliorates hepatosteatosis via several mechanisms in
ob/ob
mice
. Annals of the New York Academy of Sciences 1375:1, pages 52-65.
Crossref
Crossref
Jeffrey R. Holzberg, Ran Jin, Ngoc-Anh Le, Thomas R. Ziegler, Elizabeth M. Brunt, Craig J. McClain, Juna V. Konomi, Gavin E. Arteel & Miriam B. Vos. (2016) Plasminogen Activator Inhibitor-1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight. Journal of Pediatric Gastroenterology & Nutrition 62:6, pages 819-823.
Crossref
Crossref
Kaiping Wang, Peng Cao, Hanxiang Wang, Zhuohong Tang, Na Wang, Jinglin Wang & Yu Zhang. (2016) Chronic administration of Angelica sinensis polysaccharide effectively improves fatty liver and glucose homeostasis in high-fat diet-fed mice. Scientific Reports 6:1.
Crossref
Crossref
Yanjun Liu, Di Shi, Yuntao Liu, Yanlei Zhao, Yingying Tian, Jie Xu, Jingfeng Wang & Changhu Xue. (2016) Eicosapentaenoic acid-containing phosphatidylcholine alleviated lipid accumulation in orotic acid-induced non-alcoholic fatty liver. Journal of Functional Foods 23, pages 294-305.
Crossref
Crossref
Harriet M. GunnHanna EmilssonMelissa GabrielAnn M. MaguireKatharine S. Steinbeck. (2016) Metabolic Health in Childhood Cancer Survivors: A Longitudinal Study in a Long-Term Follow-Up Clinic. Journal of Adolescent and Young Adult Oncology 5:1, pages 24-30.
Crossref
Crossref
Moon Hee Yang, Jidong Sung & Geum-Youn Gwak. (2016) The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population. Journal of Clinical Lipidology 10:2, pages 289-298.
Crossref
Crossref
Pi-Xiao Wang, Xiao-Jing Zhang, Pengcheng Luo, Xi Jiang, Peng Zhang, Junhong Guo, Guang-Nian Zhao, Xueyong Zhu, Yan Zhang, Sijun Yang & Hongliang Li. (2016) Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling. Nature Communications 7:1.
Crossref
Crossref
Raffaella Crescenzo, Francesca Bianco, Arianna Mazzoli, Antonia Giacco, Giovanna Liverini & Susanna Iossa. (2015) A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance. European Journal of Nutrition 55:1, pages 1-6.
Crossref
Crossref
Makoto Irie, Tetsuro Sohda, Akira Anan, Atsushi Fukunaga, Kazuhide Takata & Takashi Tanaka. (2017) Reduced Glutathione suppresses Oxidative Stress in
Nonalcoholic Fatty Liver Disease. Euroasian Journal of Hepato-Gastroenterology 6:1, pages 13-18.
Crossref
Crossref
Satoshi Yamagata, Kazunori Kageyama, Shingo Murasawa, Ken Tomotsune, Shoko Kawashima, Koshi Makita, Yoichi Yamamoto, Koji Shimaya, Hiroshi Numao, Yasuaki Tazawa & Yoshiji Ogawa. (2016) A Case of Nonalcoholic Steatohepatitis in a Cured Acromegalic Patient With Severe Growth Hormone Deficiency. AACE Clinical Case Reports 2:3, pages e194-e198.
Crossref
Crossref
Jill L Sherriff, Therese A O'Sullivan, Catherine Properzi, Josephine-Lee Oddo & Leon A Adams. (2016) Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes. Advances in Nutrition 7:1, pages 5-13.
Crossref
Crossref
Yu-feng Xing, Zhen Zhang, Wen-Jun Fu, Da-qiao Zhou, Ailsa Chui-ying Yuen, Daniel Kam-wah Mok, Chi-on Chan & Guang-dong Tong. (2016)
Shugan Xiaozhi Decoction Attenuates Nonalcoholic Steatohepatitis by Enhancing PPAR
and L-FABP Expressions in High-Fat-Fed Rats
. Evidence-Based Complementary and Alternative Medicine 2016, pages 1-11.
Crossref
Crossref
Yong Xie, Yi Zhang, Zebin Guo, Hongliang Zeng & Baodong Zheng. (2016) Effect of Alkaloids from Nelumbinis Plumula against Insulin Resistance of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. Journal of Diabetes Research 2016, pages 1-7.
Crossref
Crossref
Bai-Fang Wang, Ying Wang, Ran Ao, Jing Tong & Bing-Yuan Wang. (2016)
AdipoQ
T45 G and G276 T Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease Among Asian Populations: A Meta-Analysis and Meta-Regression
. Journal of Clinical Laboratory Analysis 30:1, pages 47-57.
Crossref
Crossref
Xiao-Yuan Bao, Bei-Bei Xu, Kai Fang, Yan Li, Yong-Hua Hu & Guo-Pei Yu. (2015) Changing trends of hospitalisation of liver cirrhosis in Beijing, China. BMJ Open Gastroenterology 2:1, pages e000051.
Crossref
Crossref
Yu Gon Kim, Jae Hyeon Kim, Yong Wan Jo, Min Jung Kwun & Chang Woo Han. (2015) Kaurenoic acid, a Diterpene Derived from , Alleviates Lipogenesis in HepG2 Cells.. Journal of Korean Medicine 36:4, pages 74-79.
Crossref
Crossref
Hao-Jun Yang, Li-Ming Tang, Xian-Ju Zhou, Jun Qian, Jie Zhu, Ling Lu & Xue-Hao Wang. (2015) Ankaflavin ameliorates steatotic liver ischemia-reperfusion injury in mice. Hepatobiliary & Pancreatic Diseases International 14:6, pages 619-625.
Crossref
Crossref
Eun-Hwa Sohn, Taeseong Kim, Yong Joon Jeong, Hyo-Sang Han, Youngsung Lea, Young Mi Cho & Se Chan Kang. (2015) Triglyceride Control Effect of Agrimonia eupatoria L. in Oleic Acid Induced NAFLD-HepG2 Model. Korean Journal of Plant Resources 28:5, pages 635-640.
Crossref
Crossref
Sulin Cheng, Petri Wiklund, Reija Autio, Ronald Borra, Xiaowei Ojanen, Leiting Xu, Timo Törmäkangas & Markku Alen. (2015) Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease. PLOS ONE 10:10, pages e0138889.
Crossref
Crossref
Cathrin Sellmann, Cheng Jun Jin, Christian Degen, Jean-Pascal De Bandt & Ina Bergheim. (2015) Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis. The Journal of Nutrition 145:10, pages 2280-2286.
Crossref
Crossref
Luisa Pozzo, Laura Pucci, Guglielmo Buonamici, Lucia Giorgetti, Maristella Maltinti & Vincenzo Longo. (2015) Effect of white wheat bread and white wheat bread added with bioactive compounds on hypercholesterolemic and steatotic mice fed a high-fat diet. Journal of the Science of Food and Agriculture 95:12, pages 2454-2461.
Crossref
Crossref
S. Spahis, F. Alvarez, J. Dubois, N. Ahmed, N. Peretti & E. Levy. (2015) Plasma fatty acid composition in French-Canadian children with non-alcoholic fatty liver disease: Effect of n-3 PUFA supplementation. Prostaglandins, Leukotrienes and Essential Fatty Acids 99, pages 25-34.
Crossref
Crossref
Even Fjære, Charlotte Andersen, Lene Secher Myrmel, Rasmus Koefoed Petersen, Jakob Bondo Hansen, Hanne Sørup Tastesen, Thomas Mandrup-Poulsen, Nils Brünner, Karsten Kristiansen, Lise Madsen & Maria Unni Rømer. (2015) Tissue Inhibitor Of Matrix Metalloproteinase-1 Is Required for High-Fat Diet-Induced Glucose Intolerance and Hepatic Steatosis in Mice. PLOS ONE 10:7, pages e0132910.
Crossref
Crossref
Rabia Ergelen, Umit Akyuz, Yucel Aydin, Fatih Eren & Yusuf Yilmaz. (2015) Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 27:6, pages 667-671.
Crossref
Crossref
Norihiro Imai, Michitaka Suzuki, Kazuhiko Hayashi, Masatoshi Ishigami, Yoshiki Hirooka, Takaya Abe, Go Shioi, Hidemi Goto & Toyoshi Fujimoto. (2015) Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat Diet. PLOS ONE 10:5, pages e0127114.
Crossref
Crossref
Xian ZhangJian-Hua ZhangXu-Yang ChenQing-Hua HuMing-Xing WangRui JinQing-Yu ZhangWei WangRong WangLin-Lin KangJin-Sheng LiMeng LiYing PanJun-Jian HuangLing-Dong Kong. (2015) Reactive Oxygen Species-Induced TXNIP Drives Fructose-Mediated Hepatic Inflammation and Lipid Accumulation Through NLRP3 Inflammasome Activation. Antioxidants & Redox Signaling 22:10, pages 848-870.
Crossref
Crossref
Hong-Min Kim, Eun Soo Lee, Bo Ra Lee, Dhananjay Yadav, You Mi Kim, Hyun-Jeong Ko, Kyu Sang Park, Eun Young Lee & Choon Hee Chung. (2015) C-C Chemokine Receptor 2 Inhibitor Ameliorates Hepatic Steatosis by Improving ER Stress and Inflammation in a Type 2 Diabetic Mouse Model. PLOS ONE 10:3, pages e0120711.
Crossref
Crossref
V. Zabala, M. Tong, R. Yu, T. Ramirez, E. B. Yalcin, S. Balbo, E. Silbermann, C. Deochand, K. Nunez, S. Hecht & S. M. de la Monte. (2015) Potential Contributions of the Tobacco Nicotine-Derived Nitrosamine Ketone (NNK) in the Pathogenesis of Steatohepatitis in a Chronic Plus Binge Rat Model of Alcoholic Liver Disease. Alcohol and Alcoholism 50:2, pages 118-131.
Crossref
Crossref
Michael Kruse, Christian von Loeffelholz, Daniela Hoffmann, Antje Pohlmann, Anne-Cathrin Seltmann, Martin Osterhoff, Silke Hornemann, Olga Pivovarova, Sascha Rohn, Gerhard Jahreis & Andreas F. H. Pfeiffer. (2015) Dietary rapeseed/canola-oil supplementation reduces serum lipids and liver enzymes and alters postprandial inflammatory responses in adipose tissue compared to olive-oil supplementation in obese men. Molecular Nutrition & Food Research 59:3, pages 507-519.
Crossref
Crossref
Qin He, Jin-Ke Li, Fang Li, Ru-Gui Li, Guo-Qing Zhan, Gang Li, Wei-Xing Du & Hua-Bing Tan. (2015) Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats. World Journal of Gastroenterology 21:7, pages 2058-2066.
Crossref
Crossref
Cemal F. Subasi, Umut E. Aykut & Yusuf Yilmaz. (2015) Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 27:2, pages 137-141.
Crossref
Crossref
Min Liu, Lina Xu, Lianhong Yin, Yan Qi, Youwei Xu, Xu Han, Yanyan Zhao, Huijun Sun, Jihong Yao, Yuan Lin, Kexin Liu & Jinyong Peng. (2015) Potent effects of dioscin against obesity in mice. Scientific Reports 5:1.
Crossref
Crossref
Long-Xin Qiu. (2015) Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease. World Journal of Gastroenterology 21:4, pages 1099.
Crossref
Crossref
Jai Sun Lee, Dae Won Jun, Eun Kyung Kim, Hye Joon Jeon, Ho Hyun Nam & Waqar Khalid Saeed. (2015) Histologic and Metabolic Derangement in High-Fat, High-Fructose, and Combination Diet Animal Models. The Scientific World Journal 2015, pages 1-9.
Crossref
Crossref
Jürgen Hartler, Harald C Köfeler, Martin Trötzmüller, Gerhard G Thallinger & Friedrich Spener. (2014) Assessment of lipidomic species in hepatocyte lipid droplets from stressed mouse models. Scientific Data 1:1.
Crossref
Crossref
Francesca Maria Trovato, Daniela Catalano, Giuseppe Musumeci & Guglielmo M Trovato. (2014) 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine—recommendations for facing obesity, fatty liver and fibrosis epidemics. EPMA Journal 5:1.
Crossref
Crossref
Svitlana Shpyleva, Marta Pogribna, Christy Cozart, Matthew S. Bryant, Levan Muskhelishvili, Volodymyr P. Tryndyak, Sharon A. Ross, Frederick A. Beland & Igor P. Pogribny. (2014) Interstrain differences in the progression of nonalcoholic steatohepatitis to fibrosis in mice are associated with altered hepatic iron metabolism. The Journal of Nutritional Biochemistry 25:12, pages 1235-1242.
Crossref
Crossref
R.N. Silva, P.G. Bueno, L.R.S. Avó, K.O. Nonaka, H.S. Selistre-Araújo & A.M.O. Leal. (2014) Effect of physical training on liver expression of activin A and follistatin in a nonalcoholic fatty liver disease model in rats. Brazilian Journal of Medical and Biological Research 47:9, pages 746-752.
Crossref
Crossref
M Suzuki, M Takeda, A Kito, M Fukazawa, T Yata, M Yamamoto, T Nagata, T Fukuzawa, M Yamane, K Honda, Y Suzuki & Y Kawabe. (2014) Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models. Nutrition & Diabetes 4:7, pages e125-e125.
Crossref
Crossref
Tao Zeng, Cui-Li Zhang, Xiu-Lan Zhao & Ke-Qin Xie. (2014) Pentoxifylline for the treatment of nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 26:6, pages 646-653.
Crossref
Crossref
Sandra Barbosa-da-Silva, Natalia C. da Silva, Marcia B. Aguila & Carlos A. Mandarim-de-Lacerda. (2014) Liver damage is not reversed during the lean period in diet-induced weight cycling in mice. Hepatology Research 44:4, pages 450-459.
Crossref
Crossref
Nishika Sahini & Jürgen Borlak. (2014) Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Progress in Lipid Research 54, pages 86-112.
Crossref
Crossref
Ian James Martins & W. M. A. D. Binosha Fernando. (2014) High Fibre Diets and Alzheimer’s Disease. Food and Nutrition Sciences 05:04, pages 410-424.
Crossref
Crossref
Zeli Gao, Cheng Zhang, Liwen Jin & Wei Yao. (2014) Efficacy of Sea Buckthorn Therapy in Patients with Nonalcoholic Fatty Liver Disease. Chinese Medicine 05:04, pages 223-230.
Crossref
Crossref
Wei Tang. (2014) Role of Nrf2 in chronic liver disease. World Journal of Gastroenterology 20:36, pages 13079.
Crossref
Crossref
Toshinori Kamisako, Yuji Tanaka, Yoshizumi Kishino, Takanori Ikeda, Kazuo Yamamoto, Shiori Masuda & Hiroshi Ogawa. (2014) Role of Nrf2 in the alteration of cholesterol and bile acid metabolism-related gene expression by dietary cholesterol in high fat-fed mice. Journal of Clinical Biochemistry and Nutrition 54:2, pages 90-94.
Crossref
Crossref
Ken Kishida, Tohru Funahashi & Iichiro Shimomura. (2014) Adiponectin as a routine clinical biomarker. Best Practice & Research Clinical Endocrinology & Metabolism 28:1, pages 119-130.
Crossref
Crossref
Shuai Zhang, Lingli Zheng, Deshi Dong, Lina Xu, Lianhong Yin, Yan Qi, Xu Han, Yuan Lin, Kexin Liu & Jinyong Peng. (2013) Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats. Food Chemistry 141:3, pages 2108-2116.
Crossref
Crossref
Charlotte de Jonge, Sander S. Rensen, Ger H. Koek, Mandy F. Joosten, Wim A. Buurman, Nicole D. Bouvy & Jan Willem M. Greve. (2013) Endoscopic Duodenal–Jejunal Bypass Liner Rapidly Improves Plasma Parameters of Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology 11:11, pages 1517-1520.
Crossref
Crossref
Chrysi Koliaki & Michael Roden. (2013) Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. Molecular and Cellular Endocrinology 379:1-2, pages 35-42.
Crossref
Crossref
Fernanda Aparecida Domenici, Maria José Franco Brochado, Ana de Lourdes Candolo Martinelli, Sergio Zucoloto, Selma Freire de Carvalho da Cunha & Helio Vannucchi. (2013) Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: A study in Brazilian patients. Gene 529:2, pages 326-331.
Crossref
Crossref
Zhi-Yun Zhang, Yun-Bin Dai, Hao-Nan Wang & Ming-Wei Wang. (2013) Supplementation of the maternal diet during pregnancy with chocolate and fructose interacts with the high-fat diet of the young to facilitate the onset of metabolic disorders in rat offspring. Clinical and Experimental Pharmacology and Physiology 40:9, pages 652-661.
Crossref
Crossref
Zhong Q. Wang, Xian H. Zhang, Yongmei Yu, Russell C. Tipton, Ilya Raskin, David Ribnicky, William Johnson & William T. Cefalu. (2013) Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway. Metabolism 62:9, pages 1239-1249.
Crossref
Crossref
Llorenç Caballería, Ingrid Arteaga, Guillem Pera, Lluís Rodríguez, Alba Alumà, Maria Antònia Auladell & Pere Torán. (2013) Factores de riesgo asociados a la presencia de hígado graso no alcohólico: un estudio de casos y controles. Medicina Clínica 141:6, pages 233-239.
Crossref
Crossref
Xiangxiang Shan, Yufeng Miao, Rengen Fan, Changzhi Song, Guangzhou Wu, Zhengqiang Wan, Jian Zhu, Guan Sun, Wenzhang Zha, Xiangming Mu, Guangjun Zhou & Yan Chen. (2013) Suppression of Grb2 expression improved hepatic steatosis, oxidative stress, and apoptosis induced by palmitic acid in vitro partly through insulin signaling alteration. In Vitro Cellular & Developmental Biology - Animal 49:8, pages 576-582.
Crossref
Crossref
LIJUAN SHI, LEI SHI, HEFANG ZHANG, ZHIJUAN HU, CHAO WANG, DONGHUI ZHANG & GUANGYAO SONG. (2013) Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation. Molecular Medicine Reports 8:2, pages 439-445.
Crossref
Crossref
Tianrun LiLeiluo GengXin ChenMiranda MiskowiecXuan LiBing Dong. (2013) Branched-chain amino acids alleviate nonalcoholic steatohepatitis in rats. Applied Physiology, Nutrition, and Metabolism 38:8, pages 836-843.
Crossref
Crossref
Yoshizumi Kishino, Yuji Tanaka, Takanori Ikeda, Kazuo Yamamoto, Hiroshi Ogawa, Yoshinori Iwatani & Toshinori Kamisako. (2013) Ezetimibe Increases Hepatic Iron Levels in Mice Fed a High-Fat Diet. Journal of Pharmacology and Experimental Therapeutics 345:3, pages 483-491.
Crossref
Crossref
Liesl V. Heeks, Amanda J. Hooper, Leon A. Adams, Peter Robbins, P. Hugh R. Barrett, Frank M. van Bockxmeer & John R. Burnett. (2013) Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia. Clinica Chimica Acta 421, pages 121-125.
Crossref
Crossref
Iliana Doycheva, Niraj Patel, Michael Peterson & Rohit Loomba. (2013) Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. Journal of Diabetes and its Complications 27:3, pages 293-300.
Crossref
Crossref
Hai Yan Quan, Do Yeon Kim, Soo Jung Kim, Hee Kyung Jo, Go Woon Kim & Sung Hyun Chung. (2013) Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK–mTOR–SREBP signaling pathway. Biochemical Pharmacology 85:9, pages 1330-1340.
Crossref
Crossref
Hai Yan Quan, Soo Jung Kim, Do Yeon Kim, Hee Kyung Jo, Go Woon Kim & Sung Hyun Chung. (2013) Licochalcone A regulates hepatic lipid metabolism through activation of AMP-activated protein kinase. Fitoterapia 86, pages 208-216.
Crossref
Crossref
Jiayin Yao, Min Zhi, Xiang Gao, Pinjin Hu, Chujun Li & Xiaobo Yang. (2013) Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver. Brazilian Journal of Medical and Biological Research 46:3, pages 270-277.
Crossref
Crossref
Michelino Di Rosa, Katia Mangano, Corinne De Gregorio, Ferdinando Nicoletti & Lucia Malaguarnera. (2013) Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease. Hepatology Research 43:3, pages 267-275.
Crossref
Crossref
S.B. Wang, T. Lei, L.L. Zhou, H.L. Zheng, C.P. Zeng, N. Liu, Z.Q. Yang & X.D. Chen. (2013) Functional analysis and transcriptional regulation of porcine six transmembrane epithelial antigen of prostate 4 (STEAP4) gene and its novel variant in hepatocytes. The International Journal of Biochemistry & Cell Biology 45:3, pages 612-620.
Crossref
Crossref
Satoru Matsuda, Mayumi Kobayashi & Yasuko Kitagishi. (2013) Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease. ISRN Endocrinology 2013, pages 1-7.
Crossref
Crossref
Toshitaka Muneyuki, Kaname Suwa, Haruki Oshida, Tomoya Takaoka, Ayano Kutsuma, Tsukasa Yoshida, Masafumi Saito, Yumiko Hori, Yoshihiko Kannno, Eiichiro Kanda, Masafumi Kakei, Shin-Ichi Momomura & Kei Nakajima. (2013) Design of the Saitama Cardiometabolic Disease and Organ Impairment Study (SCDOIS): A Multidisciplinary Observational Epidemiological Study. Open Journal of Endocrine and Metabolic Diseases 03:02, pages 144-156.
Crossref
Crossref
Fernanda A. M. NASCIMENTO, Thais C. CECILIANO, Marcia B. AGUILA & Carlos A. MANDARIM-DE-LACERDA. (2013) Transgenerational Effects on the Liver and Pancreas Resulting from Maternal Vitamin D Restriction in Mice. Journal of Nutritional Science and Vitaminology 59:5, pages 367-374.
Crossref
Crossref
G. Tarantino, C. Di Somma, G. Pizza, V. Brancato, V. Nedi, R. Valentino, F. Orio, C. Pivonello, A. Colao & S. Savastano. (2013) Polycystic Ovary Syndrome and Hepatic Steatosis: Could Low-Grade Chronic Inflammation Be Mediated by the Spleen?. European Journal of Inflammation 11:1, pages 179-191.
Crossref
Crossref
Rui Li, Guifang Guo, Yuzhen Cao, Yuanyuan Wang, Fangping Liu & Xiuying Zhang. (2013) Expression of Cytochrome P450 2A5 in a C57BL/6J Mouse Model of Nonalcoholic Fatty Liver Disease. Pharmacology 92:1-2, pages 26-31.
Crossref
Crossref
Eunkyung Kim, Youngshim Choi, Jihee Jang & Taesun Park. (2013) Carvacrol Protects against Hepatic Steatosis in Mice Fed a High-Fat Diet by Enhancing SIRT1-AMPK Signaling. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-10.
Crossref
Crossref
Haiyan Zhang, Wen-Jun Shen, Yuan CortezFredric B. Kraemer & Salman Azhar. (2013) Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways. American Journal of Physiology-Gastrointestinal and Liver Physiology 304:1, pages G72-G86.
Crossref
Crossref
Displaying 200 of 217 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list